Results 21 to 30 of about 2,604,331 (176)

EpCAM-targeted near-infrared photoimmunotherapy (NIR-PIT) for the treatment of breast cancer [PDF]

open access: yesAnnals of Medicine
Background Near-infrared photoimmunotherapy (NIR-PIT) is a targeted cancer treatment that uses antibody-IR700 conjugates and selectively destroys cancer cells expressing a target antigen when exposed to near-infrared (NIR) light.
Aki Furusawa   +7 more
doaj   +2 more sources

Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models

open access: yesVaccines, 2020
Near infrared photoimmunotherapy (NIR-PIT) is a newly developed and highly selective cancer treatment that induces necrotic/immunogenic cell death. It employs a monoclonal antibody (mAb) conjugated to a photo-absorber dye, IRDye700DX, which is activated ...
Yasuhiro Maruoka   +9 more
doaj   +3 more sources

Near-infrared photoimmunotherapy using antiGD2 antibody for neuroblastoma and osteosarcoma

open access: yesEJC Paediatric Oncology
Introduction: Near-infrared photoimmunotherapy (NIR-PIT) is a novel cancer therapy that specifically targets cancer cells. In NIR-PIT, antibody-photo-absorber-conjugates (APCs), specific for cancer antigens, target cancer cells.
Jimei Zhao   +7 more
doaj   +3 more sources

Near-infrared photoimmunotherapy for recurrent cancer at the base of the tongue

open access: yesPhotodiagnosis and Photodynamic Therapy
Near-infrared photoimmunotherapy (NIR-PIT) is a novel therapeutic approach that targets epidermal growth factor receptor (EGFR). In NIR-PIT, administration of cetuximab sarotalocan sodium is followed by laser irradiation of the affected area, which ...
Takuma Makino   +6 more
doaj   +3 more sources

Targeted Elimination of Influenza Virus and Infected Cells with Near-Infrared Antiviral Photoimmunotherapy (NIR-AVPIT)

open access: yesPharmaceutics
Background: Seasonal influenza causes significant morbidity and mortality each year. Since viruses can easily acquire drug-resistant mutations, it is necessary to develop new antiviral strategies with different targets.
Terumi Mizukoshi   +6 more
doaj   +2 more sources

Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies [PDF]

open access: yesCancer Immunology, Immunotherapy
Tissue factor (TF) is a cell surface protein that plays a role in blood clotting but is also commonly expressed in many cancers. Recent research implicated TF in cancer proliferation, metastasis, angiogenesis, and immune escape.
Seiichiro Takao   +10 more
doaj   +2 more sources

Combined CD25-targeted near infrared photoimmunotherapy (NIR-PIT) and intratumor IL-15 enhance the effectiveness of anti-PD-1 immunotherapy [PDF]

open access: yesCancer Immunology, Immunotherapy
Immunotherapies aimed at enhancing anti-cancer immunity are now in wide clinical use. For instance, anti-programmed cell death protein 1 (PD-1) monoclonal antibody (mAb) therapy has demonstrated clinical efficacy in many tumor types, but overall, only a ...
Makoto Kano   +10 more
doaj   +2 more sources

Portable microcontroller-based instrument for near-infrared spectroscopy [PDF]

open access: yes, 2000
Near Infrared Spectroscopy (NIRS) can be employed to noninvasively and continuously measure in-vivo local changes in haemodynamics and oxygenation of human tissues.
Giardini, Mario Ettore   +3 more
core   +4 more sources

Near-infrared spectra of aqueous glucose solutions [PDF]

open access: yes, 2022
Infrared spectroscopy is widely utilized in the scientific community for chemical characterization of materials. Near-infrared spectroscopy relies on spectral measurements between 900 and 2,500 nm.
Lee, Tse-Ang   +2 more
core   +1 more source

Microcontroller-based digital front-end for near-infrared spectroscopy [PDF]

open access: yes, 2000
Near Infrared Spectroscopy (NIRS) can be employed to noninvasively and continuously measure in-vivo local changes in haemodynamics and oxygenation of human tissues.
Andrea Gelmetti   +17 more
core   +4 more sources

Home - About - Disclaimer - Privacy